Activation	O
of	O
c-Jun	B-protein
N-terminal	I-protein
kinase	I-protein
in	O
bacterial	B-cell_type
lipopolysaccharide-stimulated	I-cell_type
macrophages	I-cell_type
.	O

Activation	O
of	O
macrophages	B-cell_type
by	O
bacterial	O
lipopolysaccharide	O
(	O
LPS	O
)	O
induces	O
transcription	O
of	O
genes	O
that	O
encode	O
for	O
proinflammatory	B-protein
regulators	I-protein
of	O
the	O
immune	O
response	O
.	O

Previous	O
work	O
has	O
suggested	O
that	O
activation	O
of	O
the	O
transcription	B-protein
factor	I-protein
activator	I-protein
protein	I-protein
1	I-protein
(	O
AP-1	B-protein
)	O
is	O
one	O
LPS-induced	O
event	O
that	O
mediates	O
this	O
response	O
.	O

Consistent	O
with	O
this	O
notion	O
,	O
we	O
found	O
that	O
LPS	O
stimulated	O
AP-1	B-protein
-mediated	O
transcription	O
of	O
a	O
transfected	B-DNA
reporter	I-DNA
gene	I-DNA
in	O
the	O
murine	B-cell_line
macrophage	I-cell_line
cell	I-cell_line
line	I-cell_line
RAW	I-cell_line
264.7	I-cell_line
.	O

As	O
AP-1	B-protein
activity	O
is	O
regulated	O
in	O
part	O
by	O
activation	O
of	O
the	O
c-Jun	B-protein
N-terminal	I-protein
kinase	I-protein
(	O
JNK	B-protein
)	O
,	O
which	O
phosphorylates	O
and	O
subsequently	O
increases	O
the	O
transcriptional	O
activity	O
of	O
c-Jun	O
,	O
we	O
examined	O
whether	O
LPS	O
treatment	O
of	O
macrophages	B-cell_type
resulted	O
in	O
activation	O
of	O
this	O
kinase	B-protein
.	O

LPS	O
treatment	O
of	O
RAW	B-cell_line
264.7	I-cell_line
cells	I-cell_line
,	O
murine	B-cell_type
bone	I-cell_type
marrow-derived	I-cell_type
macrophages	I-cell_type
,	O
and	O
the	O
human	B-cell_line
monocyte	I-cell_line
cell	I-cell_line
line	I-cell_line
THP-1	I-cell_line
resulted	O
in	O
rapid	O
activation	O
of	O
the	O
p46	B-protein
and	I-protein
p54	I-protein
isoforms	I-protein
of	O
JNK	B-protein
.	O

Treatment	O
with	O
wild-type	O
and	O
rough	O
mutant	O
forms	O
of	O
LPS	O
and	O
synthetic	O
lipid	O
A	O
resulted	O
in	O
JNK	B-protein
activation	O
,	O
while	O
pretreatment	O
with	O
the	O
tyrosine	B-protein
kinase	I-protein
inhibitor	O
herbimycin	O
A	O
inhibited	O
this	O
response	O
.	O

Binding	O
of	O
LPS-	O
LPS	B-protein
binding	I-protein
protein	I-protein
(	I-protein
LBP	I-protein
)	I-protein
complexes	I-protein
to	O
CD14	B-protein
,	O
a	O
surface	B-protein
receptor	I-protein
that	O
mediates	O
many	O
LPS	O
responses	O
,	O
was	O
found	O
to	O
be	O
crucial	O
,	O
as	O
pretreatment	O
of	O
THP-1	B-cell_line
cells	I-cell_line
with	O
the	O
monoclonal	B-protein
antibody	I-protein
60b	I-protein
,	O
which	O
blocks	O
this	O
binding	O
,	O
inhibited	O
JNK	B-protein
activation	O
.	O

These	O
results	O
suggest	O
that	O
LPS	O
activation	O
of	O
JNK	B-protein
in	O
monocyte/macrophage	B-cell_type
cells	I-cell_type
is	O
a	O
CD14-	O
and	O
protein	O
tyrosine	O
phosphorylation-dependent	O
event	O
that	O
may	O
mediate	O
the	O
early	O
activation	O
of	O
AP-1	B-protein
in	O
regulating	O
LPS-triggered	O
gene	O
induction	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

93	NULL
,	NULL
Pp	NULL
.	NULL

2774-2778	NULL
,	NULL
April	NULL
1996	NULL
Immunology	NULL
Activation	NULL
of	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
in	NULL
bacterial	NULL
lipopolysaccharide-stimulated	NULL
macrophages	NULL
(	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
/endotoxin	NULL
/macrophages	NULL
)	NULL
JULIE	NULL
HAMBLETON*T	NULL
,	NULL
STEVEN	NULL
L.	NULL
WEINSTEINT	NULL
,	NULL
LAWRENCE	NULL
LEmt	NULL
,	NULL
AND	NULL
AntHoNY	NULL
L.	NULL
*Cancer	NULL
Research	NULL
Institute	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
°G	NULL
.	NULL

W.	NULL
Hooper	NULL
Foundation	NULL
and	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94143	NULL
Communicated	NULL
by	NULL
J.	NULL
Michael	NULL
Bishop	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
,	NULL
December	NULL
8	NULL
,	NULL
1995	NULL
(	NULL
received	NULL
for	NULL
review	NULL
October	NULL
3	NULL
,	NULL
1995	NULL
)	NULL
ABSTRACT	NULL
Activation	NULL
of	NULL
macrophages	NULL
by	NULL
bacterial	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
induces	NULL
transcription	NULL
of	NULL
genes	NULL
that	NULL
encode	NULL
for	NULL
proinflammatory	NULL
regulators	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

Previous	NULL
work	NULL
has	NULL
suggested	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
activator	NULL
protein	NULL
1	NULL
(	NULL
AP-1	NULL
)	NULL
is	NULL
one	NULL
LPS-induced	NULL
event	NULL
that	NULL
mediates	NULL
this	NULL
response	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
notion	NULL
,	NULL
we	NULL
found	NULL
that	NULL
LPS	NULL
stimulated	NULL
AP-l-mediated	NULL
transcription	NULL
of	NULL
a	NULL
transfected	NULL
reporter	NULL
gene	NULL
in	NULL
the	NULL
murine	NULL
macrophage	NULL
cell	NULL
line	NULL
RAW	NULL
264.7	NULL
.	NULL

As	NULL
AP-1	NULL
activity	NULL
is	NULL
regulated	NULL
in	NULL
part	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
,	NULL
which	NULL
phosphorylates	NULL
and	NULL
subsequently	NULL
increases	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
c-Jun	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
LPS	NULL
treatment	NULL
of	NULL
macrophages	NULL
resulted	NULL
in	NULL
activation	NULL
of	NULL
this	NULL
kinase	NULL
.	NULL

LPS	NULL
treatment	NULL
of	NULL
RAW	NULL
264.7	NULL
cells	NULL
,	NULL
murine	NULL
bone	NULL
marrow-derived	NULL
macrophages	NULL
,	NULL
and	NULL
the	NULL
human	NULL
monocyte	NULL
cell	NULL
line	NULL
THP-1	NULL
resulted	NULL
in	NULL
rapid	NULL
activation	NULL
of	NULL
the	NULL
p46	NULL
and	NULL
p54	NULL
isoforms	NULL
of	NULL
JNK	NULL
.	NULL

Treatment	NULL
with	NULL
wild-type	NULL
and	NULL
rough	NULL
mutant	NULL
forms	NULL
of	NULL
LPS	NULL
and	NULL
synthetic	NULL
lipid	NULL
A	NULL
resulted	NULL
in	NULL
JNK	NULL
activation	NULL
,	NULL
while	NULL
pretreatment	NULL
with	NULL
the	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
herbimycin	NULL
A	NULL
inhibited	NULL
this	NULL
response	NULL
.	NULL

Binding	NULL
of	NULL
LPS-LPS	NULL
binding	NULL
protein	NULL
(	NULL
LBP	NULL
)	NULL
complexes	NULL
to	NULL
CD14	NULL
,	NULL
a	NULL
surface	NULL
receptor	NULL
that	NULL
mediates	NULL
many	NULL
LPS	NULL
responses	NULL
,	NULL
was	NULL
found	NULL
to	NULL
be	NULL
crucial	NULL
,	NULL
as	NULL
pretreatment	NULL
of	NULL
THP-1	NULL
cells	NULL
with	NULL
the	NULL
monoclonal	NULL
antibody	NULL
60b	NULL
,	NULL
which	NULL
blocks	NULL
this	NULL
binding	NULL
,	NULL
inhibited	NULL
JNK	NULL
activation	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
LPS	NULL
activation	NULL
of	NULL
JNK	NULL
in	NULL
monocyte/macrophage	NULL
cells	NULL
is	NULL
a	NULL
CD14-	NULL
and	NULL
protein	NULL
tyrosine	NULL
phosphorylation-dependent	NULL
event	NULL
that	NULL
may	NULL
mediate	NULL
the	NULL
early	NULL
activation	NULL
of	NULL
AP-1	NULL
in	NULL
regulating	NULL
LPS-triggered	NULL
gene	NULL
induction	NULL
.	NULL

Upon	NULL
exposure	NULL
to	NULL
bacterial	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
a	NULL
conserved	NULL
component	NULL
of	NULL
the	NULL
Gram-negative	NULL
bacterium	NULL
's	NULL
outer	NULL
membrane	NULL
,	NULL
macrophages	NULL
release	NULL
a	NULL
large	NULL
number	NULL
of	NULL
immunoregulatory	NULL
molecules	NULL
including	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
,	NULL
interleukin	NULL
1	NULL
(	NULL
IL-1	NULL
)	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
arachidonic	NULL
acid	NULL
metabolites	NULL
that	NULL
recruit	NULL
and	NULL
activate	NULL
other	NULL
immune	NULL
cells	NULL
to	NULL
help	NULL
fight	NULL
the	NULL
bacterial	NULL
infection	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
LPS	NULL
induces	NULL
these	NULL
events	NULL
is	NULL
only	NULL
partly	NULL
understood	NULL
.	NULL

At	NULL
physiological	NULL
con-centrations	NULL
,	NULL
LPS	NULL
binds	NULL
to	NULL
the	NULL
serum	NULL
protein	NULL
LPS-binding	NULL
protein	NULL
(	NULL
LBP	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
then	NULL
interacts	NULL
with	NULL
CD14	NULL
on	NULL
macrophages	NULL
or	NULL
neutrophils	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Although	NULL
CD14	NULL
is	NULL
a	NULL
glycosyl-phosphatidylinositol-linked	NULL
protein	NULL
that	NULL
lacks	NULL
an	NULL
intracellular	NULL
domain	NULL
,	NULL
LPS-LBP	NULL
binding	NULL
to	NULL
CD14	NULL
results	NULL
in	NULL
rapid	NULL
phosphorylation	NULL
of	NULL
various	NULL
proteins	NULL
on	NULL
tyrosyl	NULL
residues	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Inhibitors	NULL
of	NULL
this	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
response	NULL
abrogate	NULL
cyto-kine	NULL
secretion	NULL
and	NULL
generation	NULL
of	NULL
eicosinoids	NULL
(	NULL
3	NULL
)	NULL
,	NULL
emphasizing	NULL
the	NULL
importance	NULL
of	NULL
this	NULL
event	NULL
in	NULL
mediating	NULL
the	NULL
macrophage	NULL
response	NULL
to	NULL
LPS	NULL
.	NULL

Among	NULL
the	NULL
most	NULL
prominently	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
in	NULL
LPS-stimulated	NULL
macrophages	NULL
are	NULL
three	NULL
members	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinase	NULL
family	NULL
,	NULL
a	NULL
group	NULL
of	NULL
related	NULL
serine/threonine	NULL
protein	NULL
kinases	NULL
that	NULL
participate	NULL
in	NULL
transmitting	NULL
extracellular	NULL
signals	NULL
to	NULL
the	NULL
cell	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

2774	NULL
interior	NULL
,	NULL
including	NULL
the	NULL
nucleus	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

The	NULL
LPS-activated	NULL
MAP	NULL
kinases	NULL
include	NULL
p42/extracellular	NULL
signal-regulated	NULL
kinase	NULL
2	NULL
(	NULL
ERK2	NULL
)	NULL
,	NULL
p44/ERK1	NULL
,	NULL
and	NULL
p38	NULL
,	NULL
the	NULL
recently	NULL
described	NULL
mammalian	NULL
homologue	NULL
of	NULL
HOG1	NULL
,	NULL
a	NULL
MAP	NULL
kinase-like	NULL
protein	NULL
that	NULL
is	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
osmotic	NULL
stress	NULL
in	NULL
yeast	NULL
(	NULL
3	NULL
)	NULL
.	NULL

These	NULL
MAP	NULL
kinases	NULL
may	NULL
be	NULL
important	NULL
mediators	NULL
of	NULL
LPS	NULL
action	NULL
in	NULL
macrophages	NULL
.	NULL

LPS	NULL
induces	NULL
transcription	NULL
of	NULL
several	NULL
genes	NULL
encoding	NULL
proinflammatory	NULL
mediators	NULL
.	NULL

A	NULL
key	NULL
issue	NULL
is	NULL
how	NULL
LPS-triggered	NULL
signaling	NULL
events	NULL
lead	NULL
to	NULL
these	NULL
gene	NULL
inductions	NULL
.	NULL

One	NULL
of	NULL
the	NULL
promoter	NULL
elements	NULL
that	NULL
contributes	NULL
to	NULL
LPS	NULL
induction	NULL
of	NULL
the	NULL
tissue	NULL
factor	NULL
gene	NULL
in	NULL
THP-1	NULL
monocytes	NULL
and	NULL
of	NULL
the	NULL
IL-6	NULL
gene	NULL
in	NULL
PU-1.8	NULL
monocytes	NULL
is	NULL
a	NULL
TPA-response	NULL
element	NULL
(	NULL
TRE	NULL
)	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

The	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
TRE	NULL
sites	NULL
are	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
activator	NULL
protein	NULL
1	NULL
(	NULL
AP-1	NULL
)	NULL
complex	NULL
,	NULL
which	NULL
consists	NULL
of	NULL
both	NULL
homodimers	NULL
and	NULL
heterodimers	NULL
of	NULL
members	NULL
of	NULL
the	NULL
Jun	NULL
family	NULL
(	NULL
c-Jun	NULL
,	NULL
JunB	NULL
,	NULL
and	NULL
JunD	NULL
)	NULL
and	NULL
heterodimers	NULL
of	NULL
members	NULL
of	NULL
the	NULL
Jun	NULL
and	NULL
Fos	NULL
(	NULL
c-Fos	NULL
,	NULL
FosB	NULL
,	NULL
Fral	NULL
,	NULL
and	NULL
Fra2	NULL
)	NULL
families	NULL
.	NULL

Regulation	NULL
of	NULL
AP-1	NULL
occurs	NULL
by	NULL
induced	NULL
transcription	NULL
of	NULL
c-jun	NULL
and	NULL
c-fos	NULL
,	NULL
or	NULL
by	NULL
posttranslational	NULL
modification	NULL
of	NULL
their	NULL
products	NULL
(	NULL
5	NULL
)	NULL
.	NULL

c-Jun	NULL
is	NULL
constitutively	NULL
present	NULL
in	NULL
cells	NULL
in	NULL
an	NULL
inactive	NULL
form	NULL
that	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
receptors	NULL
inducing	NULL
phosphorylation	NULL
of	NULL
two	NULL
serine	NULL
residues	NULL
(	NULL
serines	NULL
63	NULL
and	NULL
73	NULL
)	NULL
within	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
c-Jun	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
serines	NULL
63	NULL
and	NULL
73	NULL
appears	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
either	NULL
of	NULL
two	NULL
highly	NULL
related	NULL
c-Jun	NULL
N-terminal	NULL
protein	NULL
kinases	NULL
[	NULL
the	NULL
p46	NULL
and	NULL
p54	NULL
isoforms	NULL
of	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
]	NULL
,	NULL
which	NULL
are	NULL
members	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
family	NULL
(	NULL
5	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
physiological	NULL
concentrations	NULL
of	NULL
LPS	NULL
activate	NULL
both	NULL
isoforms	NULL
of	NULL
JNK	NULL
in	NULL
monocyte/macrophage	NULL
cells	NULL
in	NULL
a	NULL
CD14-	NULL
and	NULL
protein	NULL
tyrosine	NULL
phosphorylation-dependent	NULL
manner	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Materials	NULL
and	NULL
Antibodies	NULL
.	NULL

LPS	NULL
preparations	NULL
were	NULL
purchased	NULL
from	NULL
List	NULL
Biological	NULL
Laboratories	NULL
(	NULL
Campbell	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
that	NULL
synthetic	NULL
lipid	NULL
A	NULL
(	NULL
diphosphoryl	NULL
,	NULL
Escherichia	NULL
coli	NULL
,	NULL
and	NULL
Salmonella	NULL
types	NULL
)	NULL
and	NULL
lipid	NULL
IVa	NULL
(	NULL
LA-14-PP	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
ICN	NULL
Biomedicals	NULL
(	NULL
Irvine	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Herbimycin	NULL
A	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
B-estradiol	NULL
,	NULL
and	NULL
myelin	NULL
basic	NULL
protein	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

Anti-JNK	NULL
and	NULL
anti-ERK2	NULL
antibodies	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

1a,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
was	NULL
purchased	NULL
from	NULL
Biomol	NULL
(	NULL
Plymouth	NULL
Meeting	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

Ascites	NULL
containing	NULL
the	NULL
60b	NULL
anti-CD14	NULL
monoclonal	NULL
antibody	NULL
(	NULL
mAb	NULL
)	NULL
(	NULL
8	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
R.	NULL
Todd	NULL
(	NULL
University	NULL
of	NULL
Michigan	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
MI	NULL
)	NULL
,	NULL
and	NULL
the	NULL
antibody	NULL
was	NULL
affinity-purified	NULL
on	NULL
a	NULL
protein	NULL
A-Sepharose	NULL
column	NULL
.	NULL

The	NULL
mAb	NULL
anti-human	NULL
IgM	NULL
(	NULL
IgG1	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Southern	NULL
Biotech	NULL
(	NULL
Birmingham	NULL
,	NULL
AL	NULL
)	NULL
.	NULL

Abbreviations	NULL
:	NULL
LPS	NULL
,	NULL
lipopolysaccharide	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
AP-1	NULL
,	NULL
activator	NULL
protein	NULL
1	NULL
;	NULL
MAP	NULL
kinase	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
;	NULL
ERK	NULL
,	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
;	NULL
JNK	NULL
,	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-transferase	NULL
;	NULL
mAb	NULL
,	NULL
monoclonal	NULL
antibody	NULL
;	NULL
LBP	NULL
,	NULL
LPS	NULL
binding	NULL
protein	NULL
.	NULL

*To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Immunology	NULL
:	NULL
Hambleton	NULL
et	NULL
al	NULL
.	NULL

Plasmids	NULL
and	NULL
Expression	NULL
of	NULL
Glutathione	NULL
S-Transferase	NULL
(	NULL
GST	NULL
)	NULL
Fusion	NULL
Proteins	NULL
.	NULL

A	NULL
plasmid	NULL
encoding	NULL
the	NULL
GST-c-Jun	NULL
fusion	NULL
protein	NULL
,	NULL
pGEX3X-cJun	NULL
(	NULL
1-79	NULL
)	NULL
,	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
a	NULL
fragment	NULL
encoding	NULL
amino	NULL
acids	NULL
1-79	NULL
from	NULL
pBS-human	NULL
c-Jun	NULL
(	NULL
generously	NULL
provided	NULL
by	NULL
B.	NULL
M.	NULL
Peterlin	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
)	NULL
between	NULL
the	NULL
BamHI	NULL
and	NULL
EcoRI	NULL
sites	NULL
of	NULL
the	NULL
GST-expressing	NULL
vector	NULL
pGEX3X	NULL
(	NULL
Pharma-cia	NULL
)	NULL
.	NULL

The	NULL
1-79	NULL
amino	NULL
acid	NULL
fragment	NULL
of	NULL
c-Jun	NULL
had	NULL
been	NULL
amplified	NULL
by	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
,	NULL
using	NULL
primers	NULL
that	NULL
incorporated	NULL
BamHI	NULL
and	NULL
EcoRI	NULL
restriction	NULL
sites	NULL
at	NULL
the	NULL
5	NULL
and	NULL
3	NULL
'	NULL
ends	NULL
of	NULL
the	NULL
fragment	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
GST	NULL
fusion	NULL
protein	NULL
expression	NULL
vector	NULL
was	NULL
transformed	NULL
into	NULL
the	NULL
DH-5	NULL
«	NULL
strain	NULL
of	NULL
£	NULL
.	NULL

coli	NULL
.	NULL

Protein	NULL
induction	NULL
and	NULL
purification	NULL
were	NULL
as	NULL
described	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Cell	NULL
Culture	NULL
,	NULL
Stimulation	NULL
,	NULL
and	NULL
Cell	NULL
Lysis	NULL
.	NULL

The	NULL
macrophage	NULL
cell	NULL
lines	NULL
RAW	NULL
264.7	NULL
and	NULL
THP-1	NULL
were	NULL
obtained	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
and	NULL
maintained	NULL
as	NULL
described	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

From	NULL
48	NULL
to	NULL
72	NULL
hr	NULL
prior	NULL
to	NULL
an	NULL
experiment	NULL
,	NULL
the	NULL
THP-1	NULL
cells	NULL
were	NULL
seeded	NULL
into	NULL
a	NULL
culture	NULL
flask	NULL
at	NULL
~2.5	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
in	NULL
medium	NULL
supplemented	NULL
with	NULL
80	NULL
nM	NULL
1	NULL
@	NULL
,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
(	NULL
vitamin	NULL
D	NULL
;	NULL
)	NULL
to	NULL
induce	NULL
CD14	NULL
expression	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Transfected	NULL
RAW	NULL
264.7	NULL
cells	NULL
expressing	NULL
a	NULL
truncated	NULL
,	NULL
oncogenic	NULL
form	NULL
of	NULL
human	NULL
p74®*	NULL
``	NULL
fused	NULL
to	NULL
the	NULL
hormone-binding	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
estrogen	NULL
receptor	NULL
(	NULL
ARaf-1	NULL
:	NULL
ER	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
phenol	NULL
red-free	NULL
DMEM	NULL
supplemented	NULL
with	NULL
G418	NULL
(	NULL
1.5	NULL
mg/ml	NULL
)	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Murine	NULL
bone	NULL
marrow-derived	NULL
macrophages	NULL
were	NULL
isolated	NULL
and	NULL
cultured	NULL
in	NULL
medium	NULL
containing	NULL
20	NULL
%	NULL
L-cell-conditioned	NULL
medium	NULL
as	NULL
described	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

After	NULL
at	NULL
least	NULL
6	NULL
days	NULL
in	NULL
vitro	NULL
,	NULL
the	NULL
murine	NULL
bone	NULL
marrow	NULL
cells	NULL
were	NULL
seeded	NULL
onto	NULL
100-mm	NULL
plates	NULL
and	NULL
grown	NULL
to	NULL
60-80	NULL
%	NULL
confluency	NULL
for	NULL
experiments	NULL
.	NULL

Examination	NULL
of	NULL
cellular	NULL
responses	NULL
and	NULL
lysis	NULL
conditions	NULL
were	NULL
as	NULL
described	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Kinase	NULL
Assay	NULL
.	NULL

Triton	NULL
X-100-soluble	NULL
protein	NULL
lysates	NULL
were	NULL
precleared	NULL
with	NULL
protein	NULL
A-Sepharose	NULL
(	NULL
Pharmacia	NULL
)	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
anti-JNK	NULL
antibody	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
lysis	NULL
buffer	NULL
and	NULL
once	NULL
with	NULL
kinase	NULL
assay	NULL
buffer	NULL
(	NULL
25	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.4/20	NULL
mM	NULL
MgCl	NULL
;	NULL
/20	NULL
mM	NULL
B-glyc-erophosphate/0.1	NULL
mM	NULL
sodium	NULL
orthovanadate/2	NULL
mM	NULL
dithio-threitol	NULL
)	NULL
.	NULL

Immunocomplex	NULL
kinase	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
15	NULL
)	NULL
with	NULL
the	NULL
exception	NULL
that	NULL
reactions	NULL
were	NULL
performed	NULL
at	NULL
30°C	NULL
for	NULL
15	NULL
min	NULL
using	NULL
15-25	NULL
ug	NULL
of	NULL
GST	NULL
or	NULL
GST-c-Jun	NULL
substrate	NULL
.	NULL

In-Gel	NULL
Kinase	NULL
Assay	NULL
.	NULL

The	NULL
kinase	NULL
activity	NULL
of	NULL
JNK	NULL
was	NULL
also	NULL
assessed	NULL
by	NULL
an	NULL
in-gel	NULL
kinase	NULL
assay	NULL
,	NULL
wherein	NULL
GST-c-Jun	NULL
,	NULL
the	NULL
JNK	NULL
substrate	NULL
,	NULL
was	NULL
copolymerized	NULL
into	NULL
the	NULL
polyacrylamide	NULL
gel	NULL
as	NULL
described	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Transient	NULL
Transfection	NULL
.	NULL

The	NULL
AP-1	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
,	NULL
AP-1Lux	NULL
,	NULL
was	NULL
generously	NULL
provided	NULL
by	NULL
G.	NULL
Crabtree	NULL
(	NULL
Stan-ford	NULL
University	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

This	NULL
plasmid	NULL
,	NULL
derived	NULL
from	NULL
X3CAT	NULL
,	NULL
contains	NULL
the	NULL
luciferase	NULL
gene	NULL
under	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
three	NULL
synthetic	NULL
AP-1	NULL
sites	NULL
and	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
early	NULL
promoter	NULL
(	NULL
17	NULL
)	NULL
.	NULL

For	NULL
transfection	NULL
experiments	NULL
,	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
dislodged	NULL
from	NULL
tissue	NULL
culture	NULL
dishes	NULL
with	NULL
a	NULL
rubber	NULL
policeman	NULL
and	NULL
transiently	NULL
transfected	NULL
in	NULL
suspension	NULL
using	NULL
DEAE-dextran	NULL
as	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
pools	NULL
of	NULL
3	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
each	NULL
transfected	NULL
with	NULL
22.5	NULL
ug	NULL
of	NULL
AP-1Lux	NULL
in	NULL
DEAE-dextran	NULL
(	NULL
0.2	NULL
mg/ml	NULL
)	NULL
.	NULL

Following	NULL
a	NULL
90-min	NULL
incubation	NULL
and	NULL
3-min	NULL
10	NULL
%	NULL
dimethyl	NULL
sulfoxide	NULL
shock	NULL
,	NULL
all	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
pooled	NULL
and	NULL
then	NULL
split	NULL
onto	NULL
10-cm	NULL
tissue	NULL
culture	NULL
dishes	NULL
(	NULL
10	NULL
'	NULL
cells	NULL
per	NULL
dish	NULL
)	NULL
.	NULL

Approximately	NULL
40	NULL
hr	NULL
posttransfection	NULL
,	NULL
the	NULL
dishes	NULL
were	NULL
treated	NULL
with	NULL
LPS	NULL
or	NULL
PMA	NULL
as	NULL
indicated	NULL
.	NULL

At	NULL
the	NULL
completion	NULL
of	NULL
the	NULL
stimulation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
the	NULL
luciferase	NULL
activity	NULL
in	NULL
each	NULL
lysate	NULL
was	NULL
measured	NULL
with	NULL
an	NULL
Optocomp	NULL
I	NULL
luminometer	NULL
(	NULL
MGM	NULL
Instruments	NULL
,	NULL
Hamden	NULL
,	NULL
CT	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufac-turers	NULL
'	NULL
protocol	NULL
(	NULL
luciferase	NULL
assay	NULL
system	NULL
catalog	NULL
no	NULL
.	NULL

E1500	NULL
;	NULL
Promega	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
2775	NULL
RESULTS	NULL
LPS	NULL
Stimulates	NULL
AP-1	NULL
Transactivation	NULL
in	NULL
RAW	NULL
264.7	NULL
Macrophages	NULL
.	NULL

The	NULL
promoters	NULL
of	NULL
the	NULL
tissue	NULL
factor	NULL
and	NULL
IL-6	NULL
genes	NULL
contain	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
AP-1	NULL
transcription	NULL
factor	NULL
complex	NULL
,	NULL
and	NULL
these	NULL
sites	NULL
are	NULL
necessary	NULL
for	NULL
full	NULL
LPS	NULL
responsiveness	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
LPS	NULL
promotes	NULL
AP-1	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
19-21	NULL
)	NULL
.	NULL

However	NULL
,	NULL
LPS	NULL
stimulation	NULL
of	NULL
AP-1	NULL
transactivation	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
demonstrated	NULL
.	NULL

We	NULL
examined	NULL
this	NULL
issue	NULL
by	NULL
using	NULL
an	NULL
AP-1-driven	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
transiently	NULL
transfected	NULL
into	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

LPS	NULL
stimulated	NULL
AP-1	NULL
transactivation	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
,	NULL
that	NULL
was	NULL
detected	NULL
following	NULL
1	NULL
h	NULL
of	NULL
LPS	NULL
treatment	NULL
and	NULL
was	NULL
maximal	NULL
by	NULL
2.5-3	NULL
h	NULL
of	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

PMA	NULL
also	NULL
stimulated	NULL
AP-1	NULL
transactivation	NULL
,	NULL
although	NULL
the	NULL
response	NULL
lagged	NULL
behind	NULL
that	NULL
with	NULL
LPS	NULL
.	NULL

Thus	NULL
,	NULL
LPS	NULL
induces	NULL
rapid	NULL
AP-1	NULL
transactivation	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
this	NULL
transcription	NULL
factor	NULL
complex	NULL
participating	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
LPS-inducible	NULL
genes	NULL
.	NULL

Activation	NULL
of	NULL
JNK	NULL
Occurs	NULL
in	NULL
Response	NULL
to	NULL
LPS	NULL
Stimulation	NULL
of	NULL
Macrophages	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
LPS	NULL
to	NULL
rapidly	NULL
increase	NULL
AP-1	NULL
transactivation	NULL
suggested	NULL
that	NULL
it	NULL
might	NULL
be	NULL
able	NULL
to	NULL
activate	NULL
preexisting	NULL
c-Jun	NULL
in	NULL
these	NULL
cells	NULL
via	NULL
the	NULL
JNK	NULL
pathway	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
LPS	NULL
stimulation	NULL
of	NULL
macrophages	NULL
resulted	NULL
in	NULL
activation	NULL
of	NULL
JNK	NULL
,	NULL
the	NULL
p46	NULL
and	NULL
p54	NULL
isoforms	NULL
of	NULL
JNK	NULL
were	NULL
immunoprecipitated	NULL
from	NULL
protein	NULL
lysates	NULL
of	NULL
unstimulated	NULL
as	NULL
well	NULL
as	NULL
LPS-and	NULL
PMA-stimulated	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
immunoprecipitated	NULL
JNK	NULL
was	NULL
assessed	NULL
using	NULL
GST-c-Jun	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

LPS	NULL
stimulation	NULL
resulted	NULL
in	NULL
increased	NULL
phosphorylation	NULL
of	NULL
GST-c-Jun	NULL
by	NULL
JNK	NULL
,	NULL
but	NULL
not	NULL
of	NULL
GST	NULL
,	NULL
demonstrating	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
assay	NULL
for	NULL
c-Jun	NULL
sequences	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Anti-JNK	NULL
immunoprecipitates	NULL
from	NULL
LPS-stimulated	NULL
RAW	NULL
264.7	NULL
cells	NULL
catalyzed	NULL
phosphorylation	NULL
of	NULL
myelin	NULL
basic	NULL
protein	NULL
but	NULL
to	NULL
a	NULL
much	NULL
lesser	NULL
extent	NULL
than	NULL
anti-ERK2	NULL
immunoprecipitates	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Anti-ERK2	NULL
immunoprecipitates	NULL
did	NULL
not	NULL
phosphorylate	NULL
the	NULL
GST-c-Jun	NULL
substrate	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
LPS-induced	NULL
phosphorylation	NULL
of	NULL
GST-c-Jun	NULL
was	NULL
likely	NULL
not	NULL
due	NULL
to	NULL
activated	NULL
p38	NULL
MAP	NULL
kinase	NULL
as	NULL
purified	NULL
p38	NULL
does	NULL
not	NULL
phosphorylate	NULL
this	NULL
substrate	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
previously	NULL
demonstrated	NULL
that	NULL
activation	NULL
of	NULL
a	NULL
fusion	NULL
protein	NULL
between	NULL
oncogenic	NULL
Raf-1	NULL
and	NULL
the	NULL
ligand-binding	NULL
domain	NULL
of	NULL
the	NULL
estrogen	NULL
receptor	NULL
,	NULL
ARaf-1	NULL
:	NULL
ER	NULL
,	NULL
expressed	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
was	NULL
sufficient	NULL
to	NULL
activate	NULL
ERK1	NULL
and	NULL
ERK2	NULL
(	NULL
11	NULL
)	NULL
;	NULL
however	NULL
,	NULL
it	NULL
did	NULL
not	NULL
activate	NULL
JNK	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
phorbol	NULL
ester	NULL
PMA	NULL
,	NULL
which	NULL
also	NULL
100	NULL
3	NULL
x	NULL
75	NULL
7	NULL
80	NULL
10	NULL
[	NULL
o	NULL
0000	NULL
£	NULL
0	NULL
0	NULL
0	NULL
0	NULL
ooo	NULL
oo	NULL
§	NULL
507	NULL
-	NULL
000	NULL
/	NULL
00000	NULL
gst	NULL
230	NULL
§	NULL
|	NULL
_-	NULL
_/	NULL
_	NULL
a	NULL
57	NULL
FA	NULL
J	NULL
-B-	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
-*	NULL
w-G~-	NULL
PMA	NULL
(	NULL
100	NULL
nM	NULL
)	NULL
0	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Time	NULL
,	NULL
h	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

_	NULL
LPS	NULL
stimulates	NULL
AP-1	NULL
transactivation	NULL
in	NULL
RAW	NULL
264.7	NULL
macrophages	NULL
.	NULL

Cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
an	NULL
AP-l-regulated	NULL
luciferase	NULL
plasmid	NULL
,	NULL
pooled	NULL
,	NULL
and	NULL
then	NULL
evenly	NULL
split	NULL
onto	NULL
tissue	NULL
culture	NULL
dishes	NULL
.	NULL

Approximately	NULL
40	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
S.	NULL
minnesota	NULL
R595	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
or	NULL
100	NULL
nM	NULL
PMA	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Following	NULL
stimulation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
the	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
with	NULL
a	NULL
luminometer	NULL
.	NULL

Each	NULL
data	NULL
point	NULL
is	NULL
the	NULL
average	NULL
of	NULL
two	NULL
independent	NULL
samples	NULL
;	NULL
error	NULL
bars	NULL
indicate	NULL
range	NULL
.	NULL

Two	NULL
additional	NULL
experiments	NULL
gave	NULL
similar	NULL
results	NULL
.	NULL

2776	NULL
Immunology	NULL
:	NULL
Hambleton	NULL
et	NULL
al	NULL
.	NULL

RAW	NULL
264.7	NULL
RAW	NULL
:	NULL
ARaf-1	NULL
:	NULL
ER	NULL
Substrate	NULL
:	NULL
_	NULL
GST-cJun	NULL
GST	NULL
GST-cJun	NULL
GST	NULL
@	NULL
PFO	NULL
PELL	NULL
g	NULL
»	NULL
P	NULL
#	NULL
--	NULL
50	NULL
GST-cJun	NULL
-	NULL
#	NULL
cas	NULL
comm	NULL
--	NULL
5G	NULL
GST-	NULL
»	NULL
--	NULL
30	NULL
FiG	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Enzymatic	NULL
activation	NULL
of	NULL
JNK	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
.	NULL

Anti-JNK	NULL
immunoprecipitates	NULL
from	NULL
unstimulated	NULL
(	NULL
US	NULL
)	NULL
,	NULL
R595	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
;	NULL
15	NULL
min	NULL
)	NULL
-	NULL
or	NULL
PMA	NULL
(	NULL
100	NULL
nM	NULL
;	NULL
15	NULL
min	NULL
)	NULL
-treated	NULL
RAW	NULL
264.7	NULL
cells	NULL
or	NULL
from	NULL
unstimulated	NULL
(	NULL
US	NULL
)	NULL
,	NULL
R595	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
;	NULL
15	NULL
min	NULL
)	NULL
-	NULL
or	NULL
estradiol	NULL
(	NULL
E2	NULL
;	NULL
1	NULL
uM	NULL
;	NULL
20	NULL
min	NULL
)	NULL
-treated	NULL
RAW	NULL
:	NULL
ARaf-1	NULL
:	NULL
ER	NULL
transfectants	NULL
were	NULL
incubated	NULL
with	NULL
either	NULL
GST-c-Jun	NULL
or	NULL
GST	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
and	NULL
resolved	NULL
on	NULL
SDS/PAGE	NULL
.	NULL

Molecular	NULL
size	NULL
standards	NULL
(	NULL
kDa	NULL
)	NULL
are	NULL
indicated	NULL
to	NULL
the	NULL
right	NULL
of	NULL
the	NULL
gel	NULL
.	NULL

activates	NULL
ERK1	NULL
and	NULL
ERK2	NULL
strongly	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
11	NULL
,	NULL
23	NULL
)	NULL
,	NULL
did	NULL
not	NULL
activate	NULL
JNK	NULL
,	NULL
despite	NULL
prolonged	NULL
exposure	NULL
up	NULL
to	NULL
6	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
activation	NULL
of	NULL
Raf-1	NULL
or	NULL
the	NULL
ERK	NULL
pathway	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
activate	NULL
JNK	NULL
in	NULL
macrophages	NULL
.	NULL

Activation	NULL
of	NULL
JNK	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
was	NULL
rapid	NULL
,	NULL
occurring	NULL
by	NULL
5	NULL
min	NULL
of	NULL
stimulation	NULL
,	NULL
reached	NULL
a	NULL
maximum	NULL
by	NULL
20	NULL
min	NULL
,	NULL
and	NULL
declined	NULL
thereafter	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

This	NULL
induced	NULL
activity	NULL
was	NULL
detectable	NULL
at	NULL
100	NULL
pg/ml	NULL
and	NULL
was	NULL
maximal	NULL
at	NULL
1	NULL
ug/ml	NULL
!	NULL

(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

LPS-induced	NULL
JNK	NULL
activation	NULL
also	NULL
occurred	NULL
in	NULL
murine	NULL
bone	NULL
marrow-derived	NULL
macrophages	NULL
and	NULL
in	NULL
the	NULL
human	NULL
monocyte	NULL
cell	NULL
line	NULL
THP-1	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
is	NULL
a	NULL
generalized	NULL
response	NULL
in	NULL
macrophage	NULL
cells	NULL
.	NULL

The	NULL
kinetics	NULL
and	NULL
dose-response	NULL
that	NULL
characterized	NULL
JNK	NULL
activation	NULL
in	NULL
LPS-stimulated	NULL
THP-1	NULL
cells	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
found	NULL
in	NULL
the	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Stimulus	NULL
Specificity	NULL
of	NULL
JNK	NULL
Activation	NULL
.	NULL

Wild-type	NULL
LPS	NULL
consists	NULL
of	NULL
two	NULL
structural	NULL
domains	NULL
:	NULL
a	NULL
carbohydrate	NULL
O-region	NULL
,	NULL
which	NULL
is	NULL
variable	NULL
among	NULL
different	NULL
bacteria	NULL
,	NULL
and	NULL
a	NULL
conserved	NULL
lipid	NULL
region	NULL
,	NULL
lipid	NULL
A	NULL
.	NULL

The	NULL
predominant	NULL
biological	NULL
activity	NULL
of	NULL
the	NULL
LPS	NULL
molecule	NULL
is	NULL
contained	NULL
in	NULL
the	NULL
lipid	NULL
A	NULL
domain	NULL
,	NULL
although	NULL
the	NULL
variable	NULL
O-antigen	NULL
structures	NULL
may	NULL
be	NULL
the	NULL
major	NULL
target	NULL
for	NULL
the	NULL
host	NULL
's	NULL
anti-LPS	NULL
immune	NULL
response	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
different	NULL
forms	NULL
of	NULL
LPS	NULL
could	NULL
stimulate	NULL
JNK	NULL
activation	NULL
A	NULL
Time	NULL
:	NULL
0	NULL
1	NULL
25	NULL
55	NULL
10°	NULL
20°	NULL
30°	NULL
1h	NULL
2h	NULL
«	NULL
«	NULL
«	NULL
»	NULL
<	NULL
b	NULL
Gib	NULL
Can	NULL
--	NULL
coB	NULL
[	NULL
LPS	NULL
]	NULL
pg/ml	NULL
ng/ml	NULL
ug/ml	NULL
u-	NULL
came	NULL
ID	NULL
mus	NULL
FiG	NULL
.	NULL

3	NULL
.	NULL

-	NULL
Kinetics	NULL
and	NULL
dose-response	NULL
of	NULL
LPS-induced	NULL
JNK	NULL
activation	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
R595	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
(	NULL
4	NULL
)	NULL
or	NULL
with	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
R595	NULL
LPS	NULL
for	NULL
15	NULL
min	NULL
(	NULL
B	NULL
)	NULL
.	NULL

JNK	NULL
activity	NULL
was	NULL
assessed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
RAW	NULL
264.7	NULL
BM	NULL
/	NULL
6	NULL
1	NULL
I	NULL
6	NULL
1	NULL
I	NULL
6	NULL
]	NULL
-	NULL
»	NULL
P	NULL
>	NULL
w*	NULL
$	NULL
q	NULL
we	NULL
g	NULL
&	NULL
THP-1	NULL
<	NULL
n	NULL
comme	NULL
a	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

Activation	NULL
of	NULL
JNK	NULL
in	NULL
different	NULL
macrophage	NULL
populations	NULL
by	NULL
different	NULL
forms	NULL
of	NULL
LPS	NULL
.	NULL

RAW	NULL
264.7	NULL
cells	NULL
,	NULL
murine	NULL
bone-marrow-derived	NULL
macrophages	NULL
(	NULL
BM	NULL
)	NULL
,	NULL
and	NULL
vitamin	NULL
THP-1	NULL
cells	NULL
were	NULL
incubated	NULL
(	NULL
in	NULL
separate	NULL
experiments	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
S.	NULL
minnesota	NULL
R595	NULL
LPS	NULL
,	NULL
synthetic	NULL
lipid	NULL
A	NULL
(	NULL
LA	NULL
)	NULL
,	NULL
lipid	NULL
IVa	NULL
,	NULL
or	NULL
S.	NULL
minnesota	NULL
smooth	NULL
LPS	NULL
(	NULL
WT	NULL
)	NULL
for	NULL
15	NULL
min	NULL
(	NULL
all	NULL
[	NULL
LPS	NULL
]	NULL
1	NULL
ug/ml	NULL
)	NULL
.	NULL

JNK	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2.	NULL
in	NULL
the	NULL
RAW	NULL
264.7	NULL
and	NULL
murine	NULL
bone	NULL
marrow-derived	NULL
macrophages	NULL
.	NULL

Stimulation	NULL
with	NULL
rough	NULL
LPS	NULL
from	NULL
Salmonella	NULL
minnesota	NULL
R595	NULL
,	NULL
which	NULL
lacks	NULL
most	NULL
of	NULL
the	NULL
O-region	NULL
carbohydrate	NULL
domain	NULL
,	NULL
wild-type	NULL
smooth	NULL
LPS	NULL
from	NULL
both	NULL
S.	NULL
minnesota	NULL
and	NULL
E.	NULL
coli	NULL
(	NULL
K235	NULL
,	NULL
055	NULL
:	NULL
B5	NULL
,	NULL
and	NULL
0111	NULL
:	NULL
B4	NULL
)	NULL
,	NULL
synthetic	NULL
lipid	NULL
A	NULL
,	NULL
or	NULL
lipid	NULL
IVa	NULL
,	NULL
which	NULL
is	NULL
a	NULL
biosynthetic	NULL
precursor	NULL
of	NULL
LPS	NULL
,	NULL
induced	NULL
activation	NULL
of	NULL
JNK	NULL
in	NULL
the	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
R595	NULL
LPS	NULL
,	NULL
wild-type	NULL
LPS	NULL
,	NULL
and	NULL
lipid	NULL
IVa	NULL
induced	NULL
JNK	NULL
activation	NULL
in	NULL
the	NULL
murine	NULL
bone	NULL
marrow-derived	NULL
macrophages	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
JNK	NULL
activation	NULL
by	NULL
LPS	NULL
is	NULL
generalizable	NULL
to	NULL
various	NULL
forms	NULL
of	NULL
LPS	NULL
and	NULL
that	NULL
the	NULL
lipid	NULL
A	NULL
moiety	NULL
is	NULL
sufficient	NULL
to	NULL
induce	NULL
this	NULL
signaling	NULL
event	NULL
.	NULL

LPS	NULL
Activates	NULL
Both	NULL
Isoforms	NULL
of	NULL
JNK	NULL
.	NULL

Two	NULL
isoforms	NULL
of	NULL
JNK	NULL
,	NULL
p46	NULL
and	NULL
p54	NULL
,	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
24	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
LPS-induced	NULL
phosphorylation	NULL
of	NULL
GST~-c-Jun	NULL
by	NULL
anti-JNK	NULL
immunoprecipitates	NULL
was	NULL
due	NULL
to	NULL
p46	NULL
'	NULL
N®	NULL
or	NULL
or	NULL
both	NULL
,	NULL
the	NULL
anti-JNK	NULL
immunoprecipitates	NULL
were	NULL
subjected	NULL
to	NULL
an	NULL
in-gel	NULL
kinase	NULL
assay	NULL
,	NULL
wherein	NULL
proteins	NULL
were	NULL
resolved	NULL
on	NULL
an	NULL
SDS/	NULL
polyacrylamide	NULL
gel	NULL
containing	NULL
GST-c-Jun	NULL
and	NULL
then	NULL
renatured	NULL
and	NULL
allowed	NULL
to	NULL
phosphorylate	NULL
the	NULL
substrate	NULL
in	NULL
situ	NULL
(	NULL
16	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
LPS	NULL
induced	NULL
strong	NULL
activation	NULL
of	NULL
both	NULL
JNK	NULL
isoforms	NULL
with	NULL
a	NULL
similar	NULL
time	NULL
course	NULL
to	NULL
that	NULL
noted	NULL
in	NULL
the	NULL
immune	NULL
complex	NULL
kinase	NULL
assays	NULL
.	NULL

Anti-JNK	NULL
immunoprecipitates	NULL
from	NULL
LPS-stimulated	NULL
RAW	NULL
264.7	NULL
cells	NULL
resolved	NULL
on	NULL
an	NULL
SDS/	NULL
polyacrylamide	NULL
gel	NULL
containing	NULL
GST	NULL
alone	NULL
or	NULL
anti-ERK2	NULL
immunoprecipitates	NULL
from	NULL
LPS-stimulated	NULL
RAW	NULL
264.7	NULL
cells	NULL
resolved	NULL
on	NULL
a	NULL
GST-c-Jun-containing	NULL
SDS/polyacrylamide	NULL
gel	NULL
did	NULL
not	NULL
phosphorylate	NULL
the	NULL
gel	NULL
substrate	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
phosphorylation	NULL
of	NULL
the	NULL
substrate	NULL
required	NULL
c-Jun	NULL
sequences	NULL
and	NULL
was	NULL
specific	NULL
for	NULL
activated	NULL
JNK	NULL
.	NULL

A	NULL
LPS	NULL
(	NULL
ng/m1	NULL
)	NULL
:	NULL
102	NULL
_	NULL
10	NULL
ps5	NULL
-	NULL
:	NULL
025	NULL
,	NULL
...	NULL
404	NULL
0	NULL
60b	NULL
(	NULL
10ug/ml	NULL
)	NULL
:	NULL
l+	NULL
—	NULL
``	NULL
+	NULL
—	NULL
``	NULL
+	NULL
—	NULL
``	NULL
+	NULL
-	NULL
II	NULL
F	NULL
..	NULL
``	NULL
+	NULL
ﬂ	NULL
the	NULL
B	NULL
US	NULL
LPS	NULL
.	NULL

g	NULL
oll	NULL
.	NULL

g	NULL
ol	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

LPS-induced	NULL
activation	NULL
of	NULL
JNK	NULL
is	NULL
inhibited	NULL
by	NULL
anti-CD14	NULL
antibodies	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

Vitamin	NULL
Ds-treated	NULL
THP-1	NULL
cells	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
15	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
lanes	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
lanes	NULL
-	NULL
)	NULL
of	NULL
60b	NULL
anti-CD14	NULL
mAb	NULL
(	NULL
IgG1	NULL
;	NULL
10	NULL
ug/ml	NULL
)	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
R595	NULL
LPS	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
for	NULL
15	NULL
min	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
a	NULL
separate	NULL
experiment	NULL
,	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
60b	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
,	NULL
an	NULL
isotype-matched	NULL
control	NULL
antibody	NULL
(	NULL
C	NULL
;	NULL
anti-IgM	NULL
;	NULL
5	NULL
ug/ml	NULL
)	NULL
,	NULL
or	NULL
no	NULL
antibody	NULL
(	NULL
lanes	NULL
-	NULL
)	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
R595	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
for	NULL
15	NULL
min	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
JNK	NULL
was	NULL
determined	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Immunology	NULL
:	NULL
Hambleton	NULL
et	NULL
al	NULL
.	NULL

Time	NULL
:	NULL
0	NULL
5°	NULL
10°	NULL
15°	NULL
20	NULL
<	NULL
4	NULL
--	NULL
p54	NULL
wikilies	NULL
.	NULL

pga	NULL
-	NULL
wlth	NULL
<	NULL
4	NULL
--	NULL
p46	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

LPS-induced	NULL
enzymatic	NULL
activation	NULL
of	NULL
the	NULL
p46	NULL
and	NULL
p54	NULL
isoforms	NULL
of	NULL
JNK	NULL
as	NULL
determined	NULL
by	NULL
the	NULL
in-gel	NULL
kinase	NULL
assay	NULL
.	NULL

Anti-JNK	NULL
immunoprecipitates	NULL
from	NULL
unstimulated	NULL
(	NULL
time	NULL
0	NULL
)	NULL
RAW	NULL
264.7	NULL
cells	NULL
or	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
R595	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
were	NULL
electrophoresed	NULL
into	NULL
SDS/polyacrylamide	NULL
gels	NULL
containing	NULL
GST-c-Jun	NULL
.	NULL

After	NULL
denaturation	NULL
and	NULL
renaturation	NULL
of	NULL
proteins	NULL
,	NULL
the	NULL
kinase	NULL
activity	NULL
was	NULL
determined	NULL
in	NULL
situ	NULL
by	NULL
phosphorylation	NULL
of	NULL
the	NULL
incorporated	NULL
GST-c-Jun	NULL
.	NULL

p46	NULL
and	NULL
p54	NULL
indicate	NULL
the	NULL
activated	NULL
isoforms	NULL
of	NULL
JNK	NULL
.	NULL

Effects	NULL
of	NULL
Herbimycin	NULL
A	NULL
on	NULL
LPS-Induced	NULL
JNK	NULL
Activation	NULL
.	NULL

Inhibitors	NULL
of	NULL
LPS-induced	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
such	NULL
as	NULL
herbimycin	NULL
A	NULL
,	NULL
block	NULL
the	NULL
secretion	NULL
of	NULL
cytokines	NULL
and	NULL
the	NULL
generation	NULL
of	NULL
eicosanoids	NULL
(	NULL
3	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
JNK	NULL
activation	NULL
is	NULL
upstream	NULL
or	NULL
downstream	NULL
of	NULL
tyrosine	NULL
kinase	NULL
action	NULL
following	NULL
LPS	NULL
stimulation	NULL
,	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
herbimycin	NULL
A	NULL
before	NULL
being	NULL
stimulated	NULL
with	NULL
LPS	NULL
or	NULL
PMA	NULL
.	NULL

JNK	NULL
activation	NULL
by	NULL
LPS	NULL
was	NULL
completely	NULL
inhibited	NULL
by	NULL
herbimycin	NULL
A	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
reported	NULL
(	NULL
23	NULL
,	NULL
25	NULL
)	NULL
,	NULL
this	NULL
dose	NULL
of	NULL
herbimycin	NULL
A	NULL
did	NULL
not	NULL
inhibit	NULL
the	NULL
activation	NULL
of	NULL
ERK2	NULL
by	NULL
PMA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
herbimycin	NULL
A	NULL
was	NULL
specific	NULL
for	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
events	NULL
and	NULL
not	NULL
due	NULL
to	NULL
general	NULL
cellular	NULL
toxicity	NULL
.	NULL

Activation	NULL
of	NULL
JNK	NULL
by	NULL
LPS	NULL
Is	NULL
CD14	NULL
Dependent	NULL
.	NULL

The	NULL
glycosyl-phosphatidylinositol-linked	NULL
surface	NULL
protein	NULL
CD14	NULL
is	NULL
expressed	NULL
primarily	NULL
on	NULL
monocyte/macrophage	NULL
cells	NULL
and	NULL
neutrophils	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
mediate	NULL
many	NULL
of	NULL
the	NULL
responses	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
LPS	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
antibodies	NULL
directed	NULL
against	NULL
CD14	NULL
inhibit	NULL
LPS	NULL
induction	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
secretion	NULL
of	NULL
various	NULL
cytokines	NULL
(	NULL
3	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
tested	NULL
whether	NULL
the	NULL
ability	NULL
of	NULL
LPS	NULL
to	NULL
activate	NULL
JNK	NULL
in	NULL
monocyte/macrophage	NULL
cells	NULL
was	NULL
also	NULL
mediated	NULL
by	NULL
CD14	NULL
.	NULL

The	NULL
human	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
the	NULL
anti-CD14	NULL
mAb	NULL
60b	NULL
(	NULL
IgG1	NULL
)	NULL
,	NULL
which	NULL
prevents	NULL
LPS-LBP	NULL
complexes	NULL
from	NULL
binding	NULL
to	NULL
CD14	NULL
(	NULL
26	NULL
)	NULL
and	NULL
inhibits	NULL
LPS-induced	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
LPS	NULL
at	NULL
various	NULL
doses	NULL
,	NULL
after	NULL
which	NULL
JNK	NULL
activation	NULL
was	NULL
assessed	NULL
by	NULL
the	NULL
immune	NULL
complex	NULL
kinase	NULL
assay	NULL
.	NULL

Inhibition	NULL
of	NULL
JNK	NULL
activation	NULL
was	NULL
complete	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
at	NULL
least	NULL
5	NULL
ug	NULL
of	NULL
anti-CD14	NULL
antibody	NULL
per	NULL
ml	NULL
prior	NULL
to	NULL
LPS	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
pretreatment	NULL
of	NULL
the	NULL
THP-1	NULL
cells	NULL
with	NULL
60b	NULL
mAb	NULL
at	NULL
5	NULL
and	NULL
10	NULL
ug/ml	NULL
!	NULL

inhibited	NULL
JNK	NULL
activation	NULL
at	NULL
all	NULL
doses	NULL
of	NULL
LPS	NULL
tested	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Pretreatment	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
other	NULL
anti-CD14	NULL
mAbs	NULL
blocked	NULL
ERK2	NULL
phosphorylation	NULL
only	NULL
at	NULL
low	NULL
concentrations	NULL
of	NULL
LPS	NULL
treatment	NULL
(	NULL
<	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
60b	NULL
antibody	NULL
blocked	NULL
at	NULL
low	NULL
as	NULL
well	NULL
as	NULL
high	NULL
concentrations	NULL
of	NULL
LPS	NULL
treatment	NULL
{	NULL
ref	NULL
.	NULL

12	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
likely	NULL
reflect	NULL
different	NULL
properties	NULL
of	NULL
these	NULL
anti-CD14	NULL
blocking	NULL
antibodies	NULL
.	NULL

LPS	NULL
:	NULL
-o	NULL
F	NULL
o-	NULL
oto	NULL
ot	NULL
+o	NULL
+o	NULL
o+	NULL
+	NULL
Herbimycin	NULL
A	NULL
:	NULL
0	NULL
Q	NULL
10	NULL
10	NULL
5	NULL
(	NULL
1°	NULL
05°01	NULL
0.05	NULL
(	NULL
ug/ml	NULL
)	NULL
aga	NULL
«	NULL
uous	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Herbimycin	NULL
A	NULL
inhibition	NULL
of	NULL
LPS-induced	NULL
JNK	NULL
activation	NULL
.	NULL

RAW	NULL
264.7	NULL
cells	NULL
were	NULL
pretreated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
herbimycin	NULL
A	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
R595	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Activation	NULL
of	NULL
JNK	NULL
was	NULL
determined	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Lanes	NULL
and	NULL
+	NULL
,	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
LPS	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
2777	NULL
Pretreatment	NULL
of	NULL
the	NULL
THP-1	NULL
cells	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
60b	NULL
per	NULL
ml	NULL
did	NULL
not	NULL
block	NULL
the	NULL
activation	NULL
of	NULL
ERK2	NULL
by	NULL
PMA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
pretreatment	NULL
with	NULL
an	NULL
isotype-matched	NULL
control	NULL
antibody	NULL
did	NULL
not	NULL
inhibit	NULL
the	NULL
LPS-induced	NULL
activation	NULL
of	NULL
JNK	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
,	NULL
arguing	NULL
that	NULL
this	NULL
event	NULL
is	NULL
mediated	NULL
by	NULL
CD14	NULL
.	NULL

DISCUSSION	NULL
LPS	NULL
stimulation	NULL
of	NULL
macrophages	NULL
results	NULL
in	NULL
a	NULL
rapid	NULL
increase	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
p42/p44	NULL
ERK	NULL
and	NULL
p38/HOG1	NULL
MAP	NULL
kinase	NULL
pathways	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
third	NULL
mammalian	NULL
MAP	NULL
kinase-like	NULL
pathway	NULL
has	NULL
been	NULL
identified	NULL
involving	NULL
JNK	NULL
,	NULL
also	NULL
known	NULL
as	NULL
the	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
(	NULL
SAPK	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
this	NULL
pathway	NULL
results	NULL
in	NULL
phosphorylation	NULL
of	NULL
the	NULL
N-terminus	NULL
of	NULL
c-Jun	NULL
and	NULL
subsequent	NULL
increase	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
transcription	NULL
(	NULL
5	NULL
)	NULL
.	NULL

LPS	NULL
stimulation	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
tissue	NULL
factor	NULL
and	NULL
IL-6	NULL
genes	NULL
in	NULL
an	NULL
AP-1-dependent	NULL
manner	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
and	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
this	NULL
report	NULL
,	NULL
LPS	NULL
rapidly	NULL
stimulates	NULL
AP-1	NULL
transactivation	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
wished	NULL
to	NULL
examine	NULL
whether	NULL
JNK	NULL
was	NULL
also	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
in	NULL
macrophages	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
LPS	NULL
stimulates	NULL
activation	NULL
of	NULL
JNK	NULL
in	NULL
RAW	NULL
264.7	NULL
macrophage	NULL
cells	NULL
in	NULL
a	NULL
rapid	NULL
and	NULL
dramatic	NULL
fashion	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
JNK	NULL
was	NULL
apparent	NULL
after	NULL
5	NULL
min	NULL
of	NULL
LPS	NULL
stimulation	NULL
,	NULL
and	NULL
was	NULL
maximal	NULL
by	NULL
20	NULL
min	NULL
.	NULL

Moreover	NULL
,	NULL
JNK	NULL
activation	NULL
appeared	NULL
to	NULL
be	NULL
a	NULL
general	NULL
feature	NULL
of	NULL
the	NULL
LPS	NULL
response	NULL
of	NULL
macrophages	NULL
as	NULL
LPS	NULL
also	NULL
stimulated	NULL
JNK	NULL
activation	NULL
in	NULL
murine	NULL
bone	NULL
marrow-derived	NULL
macrophages	NULL
and	NULL
in	NULL
human	NULL
THP-1	NULL
monocytes	NULL
.	NULL

Recently	NULL
,	NULL
LPS	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
to	NULL
activate	NULL
JNK	NULL
in	NULL
Chinese	NULL
hamster	NULL
ovary	NULL
cells	NULL
transfected	NULL
with	NULL
human	NULL
CD14	NULL
(	NULL
22	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
signaling	NULL
event	NULL
may	NULL
occur	NULL
in	NULL
other	NULL
LPS-responsive	NULL
cell	NULL
types	NULL
as	NULL
well	NULL
.	NULL

Treatment	NULL
with	NULL
wild-type	NULL
LPS	NULL
,	NULL
a	NULL
rough	NULL
mutant	NULL
form	NULL
of	NULL
LPS	NULL
,	NULL
and	NULL
the	NULL
biologically	NULL
active	NULL
moiety	NULL
of	NULL
LPS	NULL
,	NULL
lipid	NULL
A	NULL
activated	NULL
this	NULL
kinase	NULL
in	NULL
the	NULL
macrophage	NULL
cells	NULL
tested	NULL
.	NULL

This	NULL
response	NULL
was	NULL
CD14	NULL
dependent	NULL
,	NULL
as	NULL
pretreatment	NULL
of	NULL
THP-1	NULL
cells	NULL
with	NULL
a	NULL
mAb	NULL
against	NULL
CD14	NULL
abrogated	NULL
the	NULL
response	NULL
.	NULL

Additionally	NULL
,	NULL
activation	NULL
of	NULL
JNK	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
herbimycin	NULL
A	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
event	NULL
,	NULL
as	NULL
with	NULL
many	NULL
early	NULL
LPS-induced	NULL
events	NULL
,	NULL
is	NULL
dependent	NULL
on	NULL
intact	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

We	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
that	NULL
herbimycin	NULL
A	NULL
directly	NULL
inhibits	NULL
JNK	NULL
,	NULL
but	NULL
this	NULL
seems	NULL
unlikely	NULL
as	NULL
JNK	NULL
is	NULL
a	NULL
serine/threonine	NULL
kinase	NULL
and	NULL
herbimycin	NULL
A	NULL
does	NULL
not	NULL
directly	NULL
inhibit	NULL
p42/p44	NULL
ERK	NULL
activation	NULL
.	NULL

We	NULL
presume	NULL
that	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
requirement	NULL
reflects	NULL
an	NULL
important	NULL
role	NULL
for	NULL
one	NULL
or	NULL
more	NULL
tyrosine	NULL
kinases	NULL
in	NULL
LPS-induced	NULL
activation	NULL
of	NULL
the	NULL
related	NULL
MAP	NULL
kinase	NULL
pathways	NULL
.	NULL

One	NULL
interesting	NULL
feature	NULL
of	NULL
these	NULL
studies	NULL
was	NULL
that	NULL
JNK	NULL
was	NULL
not	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
of	NULL
macrophages	NULL
by	NULL
the	NULL
phorbol	NULL
ester	NULL
PMA	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
what	NULL
has	NULL
been	NULL
seen	NULL
in	NULL
a	NULL
number	NULL
of	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

JNK	NULL
activity	NULL
was	NULL
also	NULL
not	NULL
increased	NULL
upon	NULL
activation	NULL
of	NULL
ARaf-1	NULL
:	NULL
ER	NULL
in	NULL
RAW	NULL
264.7	NULL
transfectants	NULL
expressing	NULL
this	NULL
chimeric	NULL
protein	NULL
.	NULL

PMA	NULL
treatment	NULL
and	NULL
ARaf-1	NULL
:	NULL
ER	NULL
activation	NULL
do	NULL
,	NULL
however	NULL
,	NULL
result	NULL
in	NULL
rapid	NULL
and	NULL
near-complete	NULL
activation	NULL
of	NULL
ERK1	NULL
and	NULL
ERK2	NULL
(	NULL
11	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
activation	NULL
of	NULL
Raf-1	NULL
or	NULL
the	NULL
ERK	NULL
pathway	NULL
are	NULL
not	NULL
sufficient	NULL
to	NULL
activate	NULL
JNK	NULL
in	NULL
macrophages	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
PMA	NULL
treatment	NULL
did	NULL
result	NULL
in	NULL
increased	NULL
AP-1-mediated	NULL
transactivation	NULL
,	NULL
although	NULL
it	NULL
was	NULL
slower	NULL
than	NULL
that	NULL
seen	NULL
upon	NULL
LPS	NULL
treatment	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
may	NULL
be	NULL
that	NULL
AP-1	NULL
activity	NULL
could	NULL
be	NULL
increased	NULL
in	NULL
two	NULL
ways	NULL
,	NULL
one	NULL
of	NULL
which	NULL
was	NULL
independent	NULL
of	NULL
JNK	NULL
activation	NULL
.	NULL

As	NULL
PMA	NULL
stimulation	NULL
resulted	NULL
in	NULL
accumulation	NULL
of	NULL
c-fos	NULL
mRNA	NULL
in	NULL
the	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
perhaps	NULL
activation	NULL
of	NULL
the	NULL
ERK	NULL
pathway	NULL
increased	NULL
AP-1	NULL
activity	NULL
by	NULL
inducing	NULL
expression	NULL
of	NULL
c-fos	NULL
,	NULL
whose	NULL
protein	NULL
product	NULL
could	NULL
then	NULL
bind	NULL
to	NULL
preexisting	NULL
c-Jun	NULL
(	NULL
5	NULL
)	NULL
.	NULL

This	NULL
hypothesis	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
slower	NULL
activation	NULL
of	NULL
AP-1	NULL
seen	NULL
by	NULL
PMA	NULL
treatment	NULL
compared	NULL
to	NULL
that	NULL
induced	NULL
by	NULL
LPS	NULL
.	NULL

LPS	NULL
induces	NULL
expression	NULL
of	NULL
c-fos	NULL
(	NULL
ref	NULL
.	NULL

27	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
but	NULL
in	NULL
addition	NULL
activates	NULL
JNK	NULL
,	NULL
and	NULL
this	NULL
could	NULL
lead	NULL
to	NULL
the	NULL
more	NULL
rapid	NULL
AP-1	NULL
activity	NULL
.	NULL

2778	NULL
Immunology	NULL
:	NULL
Hambleton	NULL
et	NULL
al	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
three	NULL
distinct	NULL
MAP	NULL
kinase	NULL
subfamilies	NULL
(	NULL
ERK	NULL
,	NULL
JNK	NULL
,	NULL
and	NULL
p38	NULL
)	NULL
involves	NULL
dual	NULL
phosphorylation	NULL
of	NULL
tyrosine	NULL
and	NULL
threonine	NULL
residues	NULL
separated	NULL
by	NULL
a	NULL
single	NULL
residue	NULL
in	NULL
the	NULL
catalytic	NULL
domain	NULL
of	NULL
these	NULL
enzymes	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
each	NULL
of	NULL
these	NULL
three	NULL
known	NULL
subfamilies	NULL
,	NULL
there	NULL
is	NULL
a	NULL
distinct	NULL
amino	NULL
acid	NULL
between	NULL
the	NULL
phosphorylated	NULL
threonine	NULL
and	NULL
tyrosine	NULL
residues	NULL
,	NULL
and	NULL
this	NULL
likely	NULL
provides	NULL
target	NULL
specificity	NULL
for	NULL
distinct	NULL
activators	NULL
of	NULL
each	NULL
subfamily	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Reports	NULL
to	NULL
date	NULL
indicate	NULL
that	NULL
Raf-1	NULL
and	NULL
MEK1	NULL
activate	NULL
the	NULL
ERK	NULL
cascade	NULL
,	NULL
MEKK-1	NULL
and	NULL
MKK4	NULL
activates	NULL
the	NULL
JNK/SAPK	NULL
cascade	NULL
,	NULL
and	NULL
MKK3	NULL
activates	NULL
p38	NULL
(	NULL
5	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
principle	NULL
,	NULL
different	NULL
stimuli	NULL
can	NULL
activate	NULL
one	NULL
or	NULL
more	NULL
of	NULL
the	NULL
known	NULL
MAP	NULL
kinase	NULL
family	NULL
pathways	NULL
.	NULL

Numerous	NULL
mitogens	NULL
and	NULL
differentiative	NULL
stimuli	NULL
activate	NULL
the	NULL
ERK	NULL
cascade	NULL
(	NULL
29	NULL
)	NULL
,	NULL
whereas	NULL
it	NULL
is	NULL
primarily	NULL
proinflammatory	NULL
cytokines	NULL
and	NULL
environmental	NULL
stress	NULL
that	NULL
result	NULL
in	NULL
p38	NULL
activation	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
JNK	NULL
pathway	NULL
is	NULL
also	NULL
activated	NULL
by	NULL
cytokines	NULL
and	NULL
cellular	NULL
stress	NULL
(	NULL
5	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
by	NULL
costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
(	NULL
30	NULL
)	NULL
,	NULL
and	NULL
activation	NULL
of	NULL
small	NULL
GTPases	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
LPS	NULL
strongly	NULL
stimulates	NULL
all	NULL
three	NULL
of	NULL
these	NULL
MAP	NULL
kinase-like	NULL
pathways	NULL
in	NULL
macrophages	NULL
and	NULL
is	NULL
the	NULL
only	NULL
cellular	NULL
stimulant	NULL
characterized	NULL
to	NULL
date	NULL
that	NULL
does	NULL
this	NULL
.	NULL

The	NULL
mechanisms	NULL
by	NULL
which	NULL
LPS	NULL
activates	NULL
these	NULL
pathways	NULL
is	NULL
not	NULL
yet	NULL
established	NULL
.	NULL

Upon	NULL
activation	NULL
,	NULL
members	NULL
of	NULL
the	NULL
ERK	NULL
and	NULL
JNK	NULL
subfamilies	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
5	NULL
)	NULL
,	NULL
whereby	NULL
phosphorylation	NULL
of	NULL
transcription	NULL
factors	NULL
may	NULL
occur	NULL
.	NULL

Activated	NULL
ERK	NULL
phosphorylates	NULL
the	NULL
ternary	NULL
complex	NULL
factor	NULL
(	NULL
TCF	NULL
)	NULL
,	NULL
Elk-1/p62	NULL
``	NULL
C	NULL
``	NULL
,	NULL
which	NULL
mediates	NULL
c-fos	NULL
induction	NULL
via	NULL
modulation	NULL
of	NULL
the	NULL
serum	NULL
response	NULL
element	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Activated	NULL
ERK	NULL
also	NULL
phosphorylates	NULL
NF-IL6	NULL
,	NULL
which	NULL
mediates	NULL
induction	NULL
of	NULL
various	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
IL-6	NULL
and	NULL
IL-8	NULL
(	NULL
32-35	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
JNK	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
results	NULL
in	NULL
phosphorylation	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
c-Jun	NULL
and	NULL
activating	NULL
transcription	NULL
factor	NULL
2	NULL
(	NULL
ATF2	NULL
)	NULL
(	NULL
36	NULL
)	NULL
,	NULL
which	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
mediate	NULL
regulation	NULL
of	NULL
the	NULL
AP-1	NULL
complex	NULL
and	NULL
c-jun	NULL
promoter	NULL
(	NULL
5	NULL
)	NULL
.	NULL

While	NULL
it	NULL
appears	NULL
that	NULL
these	NULL
pathways	NULL
are	NULL
distinct	NULL
signaling	NULL
cascades	NULL
,	NULL
they	NULL
may	NULL
also	NULL
converge	NULL
on	NULL
particular	NULL
targets	NULL
,	NULL
such	NULL
as	NULL
the	NULL
transcription	NULL
factors	NULL
Elk-1	NULL
(	NULL
37	NULL
)	NULL
and	NULL
c-Jun	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
simultaneous	NULL
activation	NULL
of	NULL
the	NULL
three	NULL
MAP	NULL
kinase	NULL
pathways	NULL
in	NULL
LPS-stimulated	NULL
macrophages	NULL
is	NULL
an	NULL
important	NULL
mechanism	NULL
by	NULL
which	NULL
LPS-induced	NULL
signaling	NULL
events	NULL
culminate	NULL
in	NULL
transcription	NULL
of	NULL
a	NULL
number	NULL
of	NULL
immunoregulatory	NULL
genes	NULL
that	NULL
then	NULL
coordinate	NULL
the	NULL
host	NULL
's	NULL
immune	NULL
response	NULL
.	NULL

Note	NULL
Added	NULL
in	NULL
Proof	NULL
.	NULL

A	NULL
number	NULL
of	NULL
recent	NULL
reports	NULL
indicate	NULL
that	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
probably	NULL
activate	NULL
all	NULL
three	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
pathways	NULL
,	NULL
as	NULL
does	NULL
LPS	NULL
stimulation	NULL
of	NULL
monocyte/macrophage	NULL
cells	NULL
.	NULL

We	NULL
thank	NULL
Robert	NULL
Finney	NULL
and	NULL
Byron	NULL
Gallis	NULL
for	NULL
their	NULL
technical	NULL
assistance	NULL
and	NULL
S.	NULL
Harmer	NULL
,	NULL
P.	NULL
Mittlestadt	NULL
,	NULL
and	NULL
J.	NULL
Richards	NULL
for	NULL
their	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
K11	NULL
AI-01164	NULL
and	NULL
ROI	NULL
Al-33443	NULL
)	NULL
.	NULL

S.W	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
the	NULL
Freddy	NULL
Cunha	NULL
IV	NULL
Fellowship	NULL
,	NULL
Cancer	NULL
Research	NULL
Institute	NULL
.	NULL

1	NULL
.	NULL

Adams	NULL
,	NULL
D.	NULL
O	NULL
.	NULL

&	NULL
Hamilton	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

2	NULL
,	NULL
283-318	NULL
.	NULL

2	NULL
.	NULL

Morrison	NULL
,	NULL
D.C.	NULL
&	NULL
Ryan	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1987	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Med	NULL
.	NULL

38	NULL
,	NULL
417-432	NULL
.	NULL

3	NULL
.	NULL

Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

&	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

13	NULL
,	NULL
437-457	NULL
.	NULL

4	NULL
.	NULL

Cano	NULL
,	NULL
E.	NULL
&	NULL
Mahadevan	NULL
,	NULL
LC	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Trends	NULL
Biol	NULL
.	NULL

Sci	NULL
.	NULL

20	NULL
,	NULL
117-122	NULL
.	NULL

5	NULL
.	NULL

Karin	NULL
,	NULL
M.	NULL
&	NULL
Hunter	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Curr	NULL
.	NULL

Biol	NULL
.	NULL

5	NULL
,	NULL
747-757	NULL
.	NULL

10	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
(	NULL
1996	NULL
)	NULL
Mackman	NULL
,	NULL
N.	NULL
,	NULL
Brand	NULL
,	NULL
K.	NULL
&	NULL
Edgington	NULL
,	NULL
T.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174	NULL
,	NULL
1517-1526	NULL
.	NULL

Dendorfer	NULL
,	NULL
U.	NULL
,	NULL
Octtgen	NULL
,	NULL
P.	NULL
&	NULL
Libermann	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
4443-4454	NULL
.	NULL

Ashmun	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Peiper	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Rebentisch	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

&	NULL
Look	NULL
,	NULL
A.	NULL
T.	NULL
(	NULL
1987	NULL
)	NULL
Blood	NULL
69	NULL
,	NULL
886-892	NULL
.	NULL

Frankel	NULL
,	NULL
S.	NULL
,	NULL
Sohn	NULL
,	NULL
R.	NULL
&	NULL
Leinwand	NULL
,	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
1192-1196	NULL
.	NULL

Frangioni	NULL
,	NULL
J	NULL
&	NULL
Neel	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

210	NULL
,	NULL
179-187	NULL
.	NULL

Hambleton	NULL
,	NULL
J.	NULL
,	NULL
McMahon	NULL
,	NULL
M.	NULL
&	NULL
DeFranco	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182	NULL
,	NULL
147-154	NULL
.	NULL

Weinstein	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
June	NULL
,	NULL
C.	NULL
H.	NULL
&	NULL
DeFranco	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
3829-3838	NULL
.	NULL

Tushinski	NULL
,	NULL
R.J.	NULL
,	NULL
Oliver	NULL
,	NULL
I.	NULL
T.	NULL
,	NULL
Guilbert	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Tynan	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
Warner	NULL
,	NULL
J.	NULL
R.	NULL
&	NULL
Stanley	NULL
,	NULL
E.	NULL
R.	NULL
(	NULL
1982	NULL
)	NULL
Cell	NULL
28	NULL
,	NULL
71-81	NULL
.	NULL

Yi	NULL
,	NULL
T.	NULL
L.	NULL
&	NULL
Willman	NULL
,	NULL
C.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Oncogene	NULL
4	NULL
,	NULL
1081-1087	NULL
.	NULL

Derijard	NULL
,	NULL
B.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Wu	NULL
,	NULL
L.-H.	NULL
,	NULL
Barrett	NULL
,	NULL
T.	NULL
,	NULL
Su	NULL
,	NULL
B.	NULL
,	NULL
Deng	NULL
,	NULL
T.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
&	NULL
Davis	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
1025-1037	NULL
.	NULL

Hibi	NULL
,	NULL
M.	NULL
,	NULL
Lin	NULL
,	NULL
A.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
Minden	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
2135-2148	NULL
.	NULL

Lee	NULL
,	NULL
W.	NULL
,	NULL
Mitchell	NULL
,	NULL
P.	NULL
&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
741-752	NULL
.	NULL

Ausubel	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Brent	NULL
,	NULL
R.	NULL
,	NULL
Kingston	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Moore	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Seid-man	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Smith	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Struhl	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
in	NULL
Current	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Biology	NULL
,	NULL
ed	NULL
.	NULL

Janssen	NULL
,	NULL
D.	NULL
(	NULL
Wiley	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
Vol	NULL
.	NULL

1	NULL
,	NULL
Section	NULL
9.2	NULL
.	NULL

Vincenti	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Burrell	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

&	NULL
Taffet	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

150	NULL
,	NULL
204-213	NULL
.	NULL

Dokter	NULL
,	NULL
W.	NULL
H.	NULL
A.	NULL
,	NULL
Esselink	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Halie	NULL
,	NULL
M.	NULL
R.	NULL
&	NULL
Vellenga	NULL
,	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
81	NULL
,	NULL
337-343	NULL
.	NULL

Tran-Thi	NULL
,	NULL
T.-A	NULL
.	NULL

,	NULL
Decker	NULL
,	NULL
K.	NULL
&	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Hepatology	NULL
22	NULL
,	NULL
613-619	NULL
.	NULL

Raingeaud	NULL
,	NULL
J.	NULL
,	NULL
Gupta	NULL
,	NULL
S.	NULL
,	NULL
Rogers	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Dickens	NULL
,	NULL
M.	NULL
,	NULL
Han	NULL
,	NULL
J.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

&	NULL
Davis	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
7420-7426	NULL
.	NULL

Weinstein	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Sanghera	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Lemke	NULL
,	NULL
K.	NULL
,	NULL
DeFranco	NULL
,	NULL
A.	NULL
L.	NULL
&	NULL
Pelech	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
14955-14962	NULL
.	NULL

Kallunki	NULL
,	NULL
T.	NULL
,	NULL
Su	NULL
,	NULL
B.	NULL
,	NULL
Tsigelny	NULL
,	NULL
I.	NULL
,	NULL
Sluss	NULL
,	NULL
H.	NULL
K.	NULL
,	NULL
Derijard	NULL
,	NULL
B.	NULL
,	NULL
Moore	NULL
,	NULL
G.	NULL
,	NULL
Davis	NULL
,	NULL
R.	NULL
&	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

8	NULL
,	NULL
2996-3007	NULL
.	NULL

Weinstein	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Gold	NULL
,	NULL
M.	NULL
R.	NULL
&	NULL
DeFranco	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
4148-4152	NULL
.	NULL

Kitchens	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

&	NULL
Munford	NULL
,	NULL
R.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176	NULL
,	NULL
485-494	NULL
.	NULL

Introna	NULL
,	NULL
M.	NULL
,	NULL
Hamilton	NULL
,	NULL
T.	NULL
,	NULL
Kauffman	NULL
,	NULL
R.	NULL
,	NULL
Adams	NULL
,	NULL
D.	NULL
&	NULL
Bast	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

137	NULL
,	NULL
2711-2715	NULL
.	NULL

Derijard	NULL
,	NULL
B.	NULL
,	NULL
Raingeaud	NULL
,	NULL
J.	NULL
,	NULL
Barrett	NULL
,	NULL
T.	NULL
,	NULL
Wu	NULL
,	NULL
L-H.	NULL
,	NULL
Han	NULL
,	NULL
J.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

&	NULL
Davis	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
682-685	NULL
.	NULL

Marshall	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Gene	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
82-89	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
Jacinto	NULL
,	NULL
E.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Kallunki	NULL
,	NULL
T.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
&	NULL
Ben-Neriah	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
77	NULL
,	NULL
727-736	NULL
.	NULL

Voijtek	NULL
,	NULL
A	NULL
.	NULL

B	NULL
.	NULL

&	NULL
Cooper	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Cell	NULL
82	NULL
,	NULL
527-529	NULL
.	NULL

Nakajima	NULL
,	NULL
T.	NULL
,	NULL
Kinoshita	NULL
,	NULL
S.	NULL
,	NULL
Sasagawa	NULL
,	NULL
T.	NULL
,	NULL
Sasaki	NULL
,	NULL
K.	NULL
,	NULL
Naruto	NULL
,	NULL
M.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
&	NULL
Akira	NULL
,	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
2207-2211	NULL
.	NULL

Isshiki	NULL
,	NULL
H.	NULL
,	NULL
Akira	NULL
,	NULL
S.	NULL
,	NULL
Tanabe	NULL
,	NULL
O.	NULL
,	NULL
Nakajima	NULL
,	NULL
T.	NULL
,	NULL
Shimamoto	NULL
,	NULL
T.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
&	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
2757-2764	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
Isshiki	NULL
,	NULL
H.	NULL
,	NULL
Sugita	NULL
,	NULL
T.	NULL
,	NULL
Tanabe	NULL
,	NULL
O.	NULL
,	NULL
Kinoshita	NULL
,	NULL
S.	NULL
,	NULL
Nishio	NULL
,	NULL
Y.	NULL
,	NULL
Nakajima	NULL
,	NULL
T.	NULL
,	NULL
Hirano	NULL
,	NULL
T.	NULL
&	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
1897-1906	NULL
.	NULL

Matsusaka	NULL
,	NULL
T.	NULL
,	NULL
Fujikawa	NULL
,	NULL
K.	NULL
,	NULL
Nishio	NULL
,	NULL
Y.	NULL
,	NULL
Mukaida	NULL
,	NULL
N.	NULL
,	NULL
Matsu-shima	NULL
,	NULL
K.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
&	NULL
Akira	NULL
,	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
10193-10197	NULL
.	NULL

Gupta	NULL
,	NULL
S.	NULL
,	NULL
Campbell	NULL
,	NULL
D.	NULL
,	NULL
Derijard	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Davis	NULL
,	NULL
R.J.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
389-393	NULL
.	NULL

Whitmarsh	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Shore	NULL
,	NULL
P.	NULL
,	NULL
Sharrocks	NULL
,	NULL
A.	NULL
D.	NULL
&	NULL
Davis	NULL
,	NULL
R.J.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
269	NULL
,	NULL
403-407	NULL
.	NULL

Chou	NULL
,	NULL
S.-Y	NULL
.	NULL

,	NULL
Baichwal	NULL
,	NULL
V.	NULL
&	NULL
Ferrell	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

3	NULL
,	NULL
1117-1130	NULL
.	NULL

